Recall
FDAHealthFebruary 3, 2025

Instrumentation Laboratory — HemosIL LMW Heparin Controls; Part Number: 0020300200;

⚠️ Multiple complaints indicating lower than expected quality control (QC) results and in some instances QC recovery below the lower limit of the package insert acceptance range when testing is performed with HemosIL Liquid Anti-Xa and HemosIL Heparin Calibrator. In some complaints, failure to pass QC resulted in patient testing delays.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
February 3, 2025

Worldwide - US Nationwide and the countries of Algeria, Andorra, Argentina, Australia, Austria, Belarus, Brazil, Brunei, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Czech Republic, Denmark, Finland, Germany, Gibraltar, Greece, Guatemala, Hong Kong, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Kuwait, Kyrgyzstan, Lebanon, Lithuania, Macao, Malaysia, Mexico, Panama, Paraguay, Peru, Poland, Portugal, Qatar, Romania, Russia, Saudi Arabia, Serbia, South Africa, Spain, Sweden, Switzerland, Thailand, Tunisia, Turkey, United Kingdom, Uruguay, Vietnam.

What's affected?

Product
HemosIL LMW Heparin Controls; Part Number: 0020300200;
Lot code
N0330228

Additional details

Part Number: 0020300200; UDI-DI: 08426950472490; Lot Numbers: N0330228, N0632773, N0935135, N1036592, N0148986, N0441476, N0643673, N0845161, N1147397;

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 41,824 units.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.